AbSci Corporation IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| AbSci Corporation | ABSI - NASDAQ |
$15.00-$17.00 | $16.00 | $21.00 | 12.5 million | 7/22/2021 |
| J.P. Morgan, Credit Suisse, BofA Securities, Cowen, Stifel | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-30 | ||||||
AbSci Corporation Quote & Chart - Click for current quote - ABSI
IPO Boutique aggregates information on public companies and private companies, such as "ABSI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About AbSci Corporation (adapted from AbSci Corporation prospectus):
They enable the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They enable the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ABSI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.